Reperfusion treatments for acute ischemic stroke in nonagenarians
- 6 May 2020
- journal article
- editorial
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 16 (1) , 19-21
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsThe Lancet, 2014
- Safety of intravenous thrombolysis for ischaemic stroke in Asian octogenarians and nonagenariansAge and Ageing, 2014
- Safety and efficacy even after 90 years of age should prompt removal of upper age limits in systemic thrombolysis for strokeInternal and Emergency Medicine, 2014
- The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialThe Lancet, 2012
- Intravenous Thrombolysis in Nonagenarians With Ischemic StrokeStroke, 2011
- Influence of Age on Outcome From Thrombolysis in Acute StrokeStroke, 2010
- Intravenous Alteplase for Stroke in Those Older Than 80 Years OldStroke, 2010
- Is Thrombolysis Safe in the Elderly?Stroke, 2010
- Outcomes of Thrombolysis for Acute Ischemic Stroke in Octogenarians Versus NonagenariansStroke, 2010
- Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational studyThe Lancet, 2007